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Abbreviations: NOS, nitric oxide synthase; iNOS, inducible NOS; eNOS, endothelial NOS; nNOS, 
neuronal NOS; CaM, Calmodulin; NMR, nuclear magnetic resonance; CaM-eNOS complex, CaM-eNOS 
binding domain peptide in complex; PDB, Protein Data Bank; HSQC, heteronuclear single-quantum 
coherence; apoCaM, Ca2+ deplete CaM; PELDOR, pulsed electron-electron double resonance; FRET, 
fluorescence resonance energy transfer; EM, electron cryo-microscopy; SPR, surface plasmon resonance; 
CaM12, CaM protein defective in Ca2+ binding in the N-lobe EF hands with CaM D20A and D56A 
mutations; CaM34, CaM protein defective in Ca2+ binding in the C-lobe EF hands with CaM D93A and 
D129A mutations; r.m.s.d., root-mean-square distance; H/D, hydrogen/deuterium.  
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ABSTRACT: The small acidic protein Calmodulin (CaM) serves as a Ca2+ sensor and control element 
for many enzymes including nitric oxide synthase (NOS) enzymes that play major roles in key 
physiological and pathological processes. CaM binding causes a conformational change in NOS to allow 
for the electron transfer between the reductase and oxygenase domains through a process that is thought 
to be highly dynamic. In this report, NMR spectroscopy was used to determine the solution structure of 
the endothelial NOS (eNOS) peptide in complex with CaM at the lowest Ca2+ concentration (225 nM) 
required for CaM to bind to eNOS and corresponds to a physiological elevated Ca2+ level found in 
mammalian cells. Under these conditions, the CaM-eNOS complex has a Ca2+-replete C-terminal lobe 
bound the eNOS peptide and a Ca2+ free N-terminal lobe loosely associated to the eNOS peptide. With 
increasing Ca2+ concentration, the binding of Ca2+ by the N-lobe of CaM results in a stronger interaction 
with the C-terminal region of the eNOS peptide and increased α-helical structure of the peptide that may 
be part of the mechanism resulting in electron transfer from the FMN to the heme in the oxygenase domain 
of the enzyme. SPR studies performed under the same conditions show Ca2+ concentration dependent 
binding kinetics were consistent with the NMR structural results. This investigation shows that structural 
studies performed under more physiological relevant conditions provide information on subtle changes in 
structure that may not be apparent when experiments are performed in excess Ca2+ concentrations. 
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Calmodulin (CaM) is a small cytosolic Ca2+-binding protein that is able to bind and regulate hundreds of 
different intracellular proteins.1 CaM consists of two globular domains connected by a flexible central 
linker region. Each globular domain contains two EF hand pairs that are capable of binding to Ca2+. Upon 
binding of Ca2+ to the EF hands of CaM, CaM undergoes a conformational change that exposes 
hydrophobic patches on each domain that allow CaM to associate with its intracellular target proteins. The 
binding of Ca2+ to CaM is cooperative within each lobe of CaM but not between the lobes, with the C-
lobe of CaM able to bind Ca2+ with a ten-fold higher affinity than the N-lobe.2,3 The flexibility of the 
central linker connecting the N- and C-lobes of CaM allows it to adapt its conformation to optimally 
associate with its intracellular targets.4  
The target proteins bound and regulated by CaM include the nitric oxide synthase (NOS) enzymes, 
which catalyze the production of nitric oxide (•NO).5 There are three NOS isoforms in mammals: neuronal 
NOS (nNOS), endothelial NOS (eNOS), and inducible NOS (iNOS). All are all dimers, with each 
monomer containing an N-terminal oxygenase domain and a C-terminal reductase domain, connected by 
a CaM binding domain. The CaM binding domains of NOS contain the classical 1-5-8-14 CaM-binding 
motif. CaM is found to bind to this binding domain in an antiparallel fashion, with the N-lobe of CaM 
binding closer to the C-terminus of this domain, and the C-lobe of CaM binds closer to the N-terminus.6 
CaM’s interaction with eNOS and nNOS is Ca2+-dependent, requiring 200-300 nM concentrations of free 
Ca2+ to achieve half maximal activity,7,8 whereas CaM binds to iNOS regardless of intracellular Ca2+ 
concentration and is fully active at basal levels of Ca2+ (<100 nM) in the cell.9–12 The oxygenase domain 
contains binding sites for heme, tetrahydrobiopterin (H4B), and the substrate L-arginine. The reductase 
domain contains binding sites for the cofactors FMN, FAD, and NADPH.5,13  
Electron flow in the NOS enzymes occurs from the NADPH, through the FAD and FMN cofactors, to 
the heme oxygenase domain. Recent studies using pulsed electron-electron double resonance (PELDOR) 
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spectroscopy, single-molecule fluorescence resonance energy transfer (FRET) spectroscopy, and electron 
cryo-microscopy (EM) have given better insight into the CaM activated NOS mechanism.14–19 These 
studies show the NOS enzymes consist of a dimerized oxygenase domain that acts as the anchoring 
dimeric structure for the entire enzyme molecule. This is flanked by two separated reductase domains, 
that exist in an equilibrium of conformations that alternate between FAD-FMN electron transfer (input 
state) and FMN–heme electron transfer (output state) with CaM binding inducing a shift in the 
conformational equilibrium to allow efficient electron transfer in NOS enzymes. When CaM is fully bound 
to NOS, residues of CaM’s N-lobe interact with the FMN subdomain of NOS and form a bridge interaction 
that appears necessary to control the interaction between the FMN and heme.20 CaM activates NOS 
through the stabilization and precise positioning of the FMN subdomain for the shuttling of electrons from 
the FMN to the oxygenase domain. 
CaM’s interactions with the various NOS isoforms has previously been studied by surface plasmon 
resonance (SPR) and nuclear magnetic resonance (NMR).21–26 However, most structural and dynamics 
studies on CaM-NOS interactions have been performed at non-physiological conditions using either apo 
(Ca2+ free with excess chelators, such as EDTA, present) or Ca2+ saturated (greater than 1mM Ca2+) 
conditions which don’t represent the true intracellular Ca2+ concentration. Previously, we had determined 
the minimal free Ca2+ concentration needed for CaM to interact with eNOS to be 225 nM.27 In the present 
study we determined the binding kinetics and NMR structure of CaM bound to the human eNOS CaM 
binding domain peptide (CaM−eNOS complex) at a free Ca2+ concentration that represents this elevated 
intracellular Ca2+ concentration of 225 nM. A comparison was made with the less physiologically relevant 
high Ca2+ concentrations used in previous CaM-eNOS structure calculations. Our study is the first study 
to determine a solution structure of the CaM-eNOS complex at a free Ca2+ concentration that is in the 
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elevated intracellular Ca2+ concentration range. In addition, this study identifies the roles played by each 
individual lobe of CaM in the binding and activation of the eNOS enzyme.  
EXPERIMENTAL PROCEDURES 
CaM Protein Expression and Purification. Wild-type CaM protein, CaM12 (CaM protein defective in 
Ca2+ binding in the N-lobe EF hands; CaM D20A and D56A mutations) and CaM34 (CaM protein defective 
in Ca2+ binding in the C-lobe EF hands; CaM D93A and D129A mutations) were expressed and purified 
using phenyl sepharose chromatography, as previously described.28 Isolation of the CaM protein (148 
residues) was confirmed by ESI-MS and purity was judged to be > 95% by SDS-PAGE. The human eNOS 
(TRKKTFKEVANAVKISASLMGT, 22 residues corresponding to residues 491-512 from the full length 
eNOS protein) peptide was synthesized and purchased from Sigma. The eNOS peptide used for SPR was 
synthesized with an added cysteine at the carboxyl end to allow for immobilization on the gold sensor.  
Sample Preparation for NMR Investigation. CaM for NMR experiments was expressed in E. coli in 
M9 media (11.03 g/L Na2HPO4·7H2O, 3.0 g/L KH2PO4, 0.5 g/L NaCl, 2 mM MgSO4, 0.1 mM CaCl2, 5 
mg/mL Thiamine, 100 µg/mL kanamycin) containing 2 g/L 13C-glucose and 1 g/L 15NH4Cl.22 13C-15N-
CaM was purified using phenyl sepharose chromatography, as previously described.28 Isolation of the 
CaM protein (148 residues) was confirmed by ESI-MS and purity was judged to be > 95% by SDS-PAGE.  
The 225 nM free Ca2+ 13C-15N-CaM sample was prepared via a buffer exchange into 30 mM MOPS, 
100 mM KCl, 90% H2O/10% 2H2O, pH 7.2, and combination of 10 mM EGTA and 10mM CaEGTA to 
obtain a final 225 nM concentration of free Ca2+ using a YM10 centrifugal filter device (Millipore Corp., 
Billerica, USA). The sample had a final 13C-15N-CaM concentration of 1 mM in a total volume of 500 µL. 
The sample was transferred into 5 mm NMR sample tubes and stored at 4oC until required for NMR 
experiments. NMR experiments on the complex were conducted on samples titrated with eNOS peptide 
to saturation in a 1:1 CaM:peptide ratio. The eNOS peptide was run through a Chelex exchange resin prior 
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to lyophilization for the NMR titrations. Complex formation was monitored after each addition by 
acquisition of a 1H-15N heteronuclear single-quantum coherence (HSQC) spectrum.  
NMR Spectroscopy and Data Analysis. NMR spectra were recorded at 25oC on Bruker 600 MHz 
DRX spectrometers equipped with XYZ-gradients triple-resonance probes (Bruker, Billerica, MA, USA). 
Spectra were analyzed using the program CARA (Computer Aided Resonance Assignment).29 The amide 
resonances assignments were aided by using the previously obtained amide chemical shifts of Ca2+ 
saturated CaM with eNOS peptide as reference.22 Specific assignments of the backbone resonances were 
achieved using a combination of three-dimensional triple- resonance experiments, including HNCA, 
HN(CO)CA, CBCA(CO)NH, and HNCO.30–32 Side chain resonances were assigned using the TOCSY-
type HC(C)H-TOCSY and (H)CCH- TOCSY experiments.33 
Structure Calculation of CaM-eNOS Peptide at 225 nM Ca2+. The 1H, 13C, and 15N resonance 
assignments were utilized to identify constraints for the structure calculations. Distance constraints for the 
CaM-eNOS complex were obtained from 15N NOESY-HSQC and 13C NOESY- HSQC, and 15N- double-
filtered NOESY spectra acquired on samples containing 13C-15N-CaM and unlabeled peptide.34–36 In 
addition, dihedral angle restraints were derived from chemical shift analysis with TALOS+. The structure 
calculation of CaM-eNOS peptide at 225 nM Ca2+ was performed using CNSsolve version 1.2.37 The 
calculation was initiated with an extended conformation file and run through several iterations of a 
standard simulated annealing protocol to minimize the energies. The final 20 lowest energy structures 
were selected. 
Accession Numbers. The coordinates and NMR parameters have been deposited in the Protein Data 
Bank (PDB) and the BioMagResBank (BMRB) and have been assigned PDB entry 2N8J, and BMRB 
accession number 25852. 
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Surface Plasmon Resonance. SPR experiments were performed with an openSPR instrument (Nicoya 
Lifesciences, Waterloo, Canada) at 25oC with a 100 µL loading loop and a constant flow rate of 50 µL/min. 
The eNOS peptide with an added cysteine at the carboxyl end was immobilized on a gold nanoparticle 
sensor chip. Binding of CaM was tested in either saturating Ca2+ buffer (30 mM MOPS, 100 mM KCl, 
pH 7.2 and 0.1 mM CaCl2) or 225 nM free Ca2+ buffer (30 mM MOPS, 100 mM KCl, pH 7.2, and 
combination of 10 mM EGTA and 10mM CaEGTA to obtain a final 225 nM concentration of free Ca2+). 
CaM was injected over the immobilized eNOS peptide in concentrations from 10 to 500 nM for 2 minutes 
to allow association. CaM free saturating Ca2+ or 225 nM free Ca2+ buffer was passed over the sensor for 
12 minutes to allow dissociation. Following each CaM injection, 30 mM MOPS, 100 mM KCl, pH 7.2 
and 10 mM EDTA buffer was injected to completely dissociate the complex and regenerate the sensor. 
Analysis of the data was made using Trace Drawer software (Ridgeview Instruments AB) as 
recommended by the manufacturer. Kinetic parameters were calculated using global analysis, fitting the 
data to a simple 1:1 model (A + B « AB) for CaM-, CaM12- and CaM34- interactions at saturated and 225 
nM Ca2+. 
RESULTS AND DISCUSSION 
NMR experiments were performed at physiological free Ca2+ concentrations to provide further insights 
into the structural differences and dynamics of the CaM-eNOS complex. These results were compared to 
the non-physiological high Ca2+ concentrations used in past CaM-NOS structure calculations.22,38,39 At 
resting intracellular Ca2+ concentrations CaM is unable to bind to the eNOS CaM binding domain peptide, 
whereas it can bind at an elevated free Ca2+ concentration of 225 nM. At the 225 nM free Ca2+ 
concentration CaM alone does not bind Ca2+ (previously shown by dansyl-CaM fluorescence studies 27), 
however, the presence of the eNOS peptide enhances the Ca2+ affinity of the C-lobe of CaM. At resting 
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intracellular Ca2+ concentrations holo eNOS is also inactive, requiring a 200 to 300 nM free Ca2+ 
concentration to achieve half maximal activity.8,40–43 
NMR Structure at Physiological Ca2+ Concentration. The three-dimensional solution structure of 
CaM bound to the human eNOS CaM binding domain peptide (CaM−eNOS complex) at 225 nM free 
Ca2+ was determined using multidimensional heteronuclear NMR spectroscopy. The structure of the 
complex is based on a large number of experimental constraints and is well-defined. The root-mean-square 
distance (r.m.s.d.) for ordered residues is 1.9 Å for the backbone atoms and 2.2 Å for all non-hydrogen 
atoms (Table 1). The family of 20 lowest energy structures is shown in Fig. 1A. When these 20 lowest 
energy structures are aligned by the C-lobe backbone atoms of CaM, the C-lobes of CaM are shown to 
superimpose quite well with each other, whereas the N-lobe has a lot of fluctuation in its relative position 
to the C-lobe, suggesting the N-lobe is less rigid, and more dynamic, than the C-lobe. When a similar 
comparison is made with the superposition of the backbone of the 20 lowest energy structures for the 
previously determined Ca2+ saturated CaM-eNOS complex (PDB 2LL7, Fig. 1D) both the C- and N-lobes 
display fairly rigid and well overlaid structures. This less rigid, or more dynamic, N-lobe of CaM in the 
CaM-eNOS complex structure at 225 nM free Ca2+ can also be shown by looking at the r.m.s.d. values for 
each individual lobe of CaM. The r.m.s.d. for the C-lobe residues is 0.6 Å for the backbone atoms and 1.1 
Å for all non-hydrogen atoms, whereas it is 0.9 Å for the backbone atoms and 1.4 Å for all non-hydrogen 
atoms of the N-lobe. 
The CaM-eNOS complex at a physiologically relevant free Ca2+ concentration of 225 nM has a Ca2+-
replete C-lobe bound to the eNOS peptide and a Ca2+ free N-lobe loosely associated to the eNOS peptide 
in an antiparallel fashion as shown in Fig. 1B. Residues 1−4 (corresponding to residues 491−494 of eNOS) 
at the N-terminus of the eNOS CaM-binding region peptide show a lack of structure because they could 
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not be unambiguously assigned. Compared to the Ca2+ saturated CaM-eNOS complex structure (Fig. 1E) 
one can see that the N-lobe at 225 nM free Ca2+ has a much looser association to the eNOS peptide.  
The Solution Structure of CaM-eNOS at 225 nM Free Ca2+ Correlates Well with Previous 
Dynamics Data. The dynamic properties of these complexes had been previously examined by amide 
H/D exchange time-course and NMR 15N relaxation experiments and agree very well with the determined 
solution structure in this study.27 Amide exchange experiments provide detailed information on the degree 
of protection of specific residues within a protein complex and are useful for identifying residues involved 
in co-operative binding of a ligand.44,45 The NMR 15N relaxation T1, T2, and 1H-15N NOE experiments 
were used to characterize backbone mobility by determining an order parameter, S2, which may be 
interpreted to describe internal dynamics on a residue specific level.46–49 There are a few residues of the 
N-lobe that exhibit intermediate exchange, such as M36, M51, M72 and K75. These residues are all found 
to be part of α-helices and have hydrophobic interactions with L509, one of the anchoring residues of 
eNOS, in the solution structure of the complex (Fig. 1C and fig. 3C). The amides of the C-lobe residues 
that show intermediate or slow exchange correspond to CaM residues that also interact with the 1-5-8-14 
anchoring residues of the eNOS peptide in the solution structure (Fig. 3B). The 15N relaxation data also 
correlates very well with the solution structure of the CaM-eNOS complex at 225 nM Ca2+. The lower 
overall dynamics of the C-lobe of CaM compared to the N-lobe correspond well with the more rigid C-
lobe (and lower r.m.s.d. for the C-lobe) observed in the structure. Whereas the N-lobe of CaM displays 
increased backbone mobility, indicating increased dynamics, which correlates well with the less rigid N-
lobe observed by the increased fluctuations in its overall position relative to the C-lobe (Fig. 1A) and the 
N-lobe’s higher calculated r.m.s.d. value.  
This provides direct structural evidence for previous studies that show CaM bound to the NOS 
holoenzymes exists in multiple conformations with the most populated state corresponding to CaM docked 
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to the oxygenase domain (CaM binds to the oxygenase domain with its C-lobe).14–19 The more highly 
dynamic N-lobe of CaM (which interacts with the FMN subdomain of eNOS) is consistent with the 
proposed conformational sampling of the FMN subdomain.14,15    
Comparison to Previous CaM Structures. When the 225 nM free Ca2+ CaM-eNOS complex structure 
is compared to the previously determined Ca2+ saturated CaM−eNOS complex structure (PDB entry 
2LL7), one can see that the C-lobes of CaM and peptide orientation are quite similar, however the N-lobe 
of CaM is structurally different (Fig. 2A,B). When the two structures are aligned with respect to CaM’s 
C-lobe backbone atoms a r.m.s.d. value of 1.023 Å for the backbone atoms of CaM was found. The C-
lobes of CaM and the eNOS peptide of each structure superimpose quite well on each other, whereas the 
N-lobes of CaM do not. 
When the 225 nM free Ca2+ CaM-eNOS complex structure is compared to the previously determined 
apoCaM structure (PDB entry 1CFC), there is structural similarity of the N-lobes of CaM, whereas the C-
lobes of CaM show differences (Fig. 2C,D). When the two structures are aligned with respect to CaM’s 
N-lobe backbone atoms a r.m.s.d. value of 1.042 Å for the backbone atoms of CaM was found.  
The Individual Lobes of CaM Interact Differently With the eNOS Peptide at Low Ca2+ 
Concentrations. At the 225 nM free Ca2+ concentration the CaM-eNOS complex displays a structure with 
a Ca2+-replete C-lobe bound to the peptide, and a Ca2+-deplete N-lobe that is loosely associated to the 
peptide via hydrophobic interactions of a few CaM residues to the anchoring residue L509 of eNOS (Fig 
3A,C). The solution structure shows L509 situated in a hydrophobic pocket of CaM composed of N-lobe 
residues M36, M51, and M72.  
The structure of the CaM-eNOS complex at 225 nM Ca2+ shows that the C-lobe of CaM is completely 
bound to the N-terminal region of the eNOS peptide in a similar fashion as the holoCaM-eNOS complex. 
Residues V91, F92, L105, L112, F141 and M144 of the C-lobe of CaM interact via hydrophobic 
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interactions with the anchoring residues F496, A500 and V503 of the eNOS peptide (Fig 3A, B). This 
forms a tight complex between the eNOS peptide and CaM which induces this region of the eNOS peptide 
to adopt an α-helical secondary structure. The C-terminus of the eNOS peptide does not form an α-helix 
likely due to having weaker interactions with the N-lobe of CaM. This is evidenced by the solution 
structure and the lower amount of NOE contacts observed in the eNOS peptide NOESY spectrum and 
agrees very well with previous studies that show the NOS peptides have no secondary structure when not 
bound to CaM.21,50 This less structured C-terminal region of the eNOS CaM binding domain supports a 
weaker association of the N-lobe of CaM to the eNOS peptide and would allow the FMN subdomain to 
have the flexibility to sample different conformational states, correlating well with the dynamic nature of 
this region of the NOS enzyme. 
The solution structure, along with the previous amide exchange and internal mobility results, show that 
the residues of CaM interacting with eNOS’ 1-5-8-14 anchoring residues have a strong interaction at 225 
nM free Ca2+ concentration, which keeps the complex bound, while the rest of the residues of the CaM 
protein are able to fluctuate or “breathe”. Comparing the two lobes of CaM, the residues of the C-lobe 
display a more rigid structure (lower r.m.s.d., lower degree of internal mobility (higher S2) and higher 
exchange protection), indicating a stronger interaction with the N-terminal region of the eNOS peptide to 
hold the complex together and induce an α-helical structure, while the N-lobe is more dynamic and loosely 
associated to the less structured C-terminal region of the eNOS peptide. This further supports a previous 
study of CaM with a NOS isoform that showed the C-lobe of CaM first binds Ca2+, then to the nNOS 
enzyme, followed by an increase in intracellular Ca2+ concentration where the N-lobe is then able to bind 
Ca2+ and finally to the enzyme.51 
 Surface Plasmon Resonance Show Increase in Ca2+ Concentration Stabilizes the CaM-eNOS 
Complex. The interaction of the eNOS peptide with CaM at 225 nM Ca2+ was further analyzed using 
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SPR. SPR analysis allows us to determine the binding kinetics of a protein to a peptide with the advantage 
of using a label-free system. The kinetics of this binding interaction, including the binding affinity, 
association and dissociation rates, was determined by the injection of different concentrations of CaM 
over a surface with an immobilized eNOS peptide.  
Sensorgrams at various CaM concentrations (10 to 500 nM) were obtained at a saturating Ca2+ 
concentration of 0.1 mM to ensure optimal interaction of Ca2+-replete CaM with the eNOS peptide (Figure 
4). The sensorgrams consisted of three phases: an association phase, injection of buffer with CaM; a 
dissociation phase, flushing of the flow cell with CaM-free buffer; and a regeneration phase, injection of 
EDTA for complete dissociation of the complex. Sensorgrams were analyzed by a simple 1:1 (A + B « 
AB, where A is CaM and B is the immobilized eNOS peptide) fitting model using the Tracedrawer 
software (Ridgeview Instruments AB) (Figure 4 and Table 2). 
We determined the association rate, ka, to be 13.1 (± 4.84) x 104 M-1s-1 and the dissociation rate, kd, to 
be 3.47 (± 1.03) x 10-4 s-1, giving a dissociation constant, KD, of 2.68 (± 0.17) x 10-9 M for CaM at 
saturating Ca2+, which is in good agreement with previously reported values that range from 1.6 to 4.0 x 
10-9 M.21,52,53 Sensorgrams were then obtained at the 225 nM free Ca2+ concentration to evaluate the initial 
binding kinetics of CaM with the eNOS peptide. This yielded a ka of 7.79 (± 0.47) x 104 M-1s-1, kd of 8.33 
(± 0.72) x 10-4 s-1 and KD of 10.7 (± 0.28) x 10-9 M. 
To evaluate the binding kinetics of each individual Ca2+ saturated lobe of CaM to the eNOS peptide we 
performed SPR experiments at either saturating (0.1 mM CaCl2) or 225 nM free Ca2+ concentration using 
CaM constructs that are defective in Ca2+ binding in either the N-terminal lobe EF hands (CaM12; CaM 
D20A and D56A mutations) or the C-terminal lobe EF hands (CaM34; CaM D93A and D129A). The 
CaM12 construct is only able to bind Ca2+ to the C-lobe of CaM which resembles the conformation of 
wildtype CaM with the eNOS peptide at 225 nM free Ca2+. The SPR analysis showed for saturating and 
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225 nM free Ca2+ conditions CaM12 had similar binding kinetics to the eNOS peptide (KD’s of 14.4 ± 4.0 
and 18.0 ± 2.7 nM, respectively and increased dissociation rates) as wildtype CaM with the peptide at 225 
nM free Ca2+.  The SPR experiment with the CaM34 construct allows us to measure the contribution of the 
N-lobe of CaM to the binding kinetics with the eNOS peptide. The interaction of eNOS with CaM is Ca2+-
dependent, thus CaM is unable to associate with eNOS in its Ca2+ free form. The binding of CaM34 to the 
eNOS peptide was found to be very weak at 225 nM free Ca2+ (data not shown) because the C-lobe of 
CaM is incapable of binding Ca2+ and at this low Ca2+ concentration the N-lobe of CaM is unable to bind 
Ca2+ in the presence of the peptide as shown by the NMR data. At saturated Ca2+ CaM34 binds the eNOS 
peptide with the highest KD (22.7 ± 1.0 nM) revealing that when CaM only has a Ca2+ saturated N-lobe it 
has a weaker association with the peptide, showing that the C-lobe of CaM is primarily responsible for 
binding to eNOS with N-lobe binding enhancing the interaction. A comparison of the different conditions 
and constructs used in the investigation shows that a correlation exists between the binding kinetics and 
constants (Figure 5).  When only one lobe of CaM is able to interact with the eNOS peptide, the 
dissociation rates and dissociation constants are increased when compared to CaM binding the eNOS 
peptide at saturated Ca2+. 
At 225 nM free Ca2+ CaM’s binding affinity for eNOS is decreased (increased dissociation rate) 
compared to the saturating Ca2+ conditions due to having a Ca2+ saturated C-lobe tightly bound to the 
eNOS peptide, while the N-lobe is loosely associated. At this low Ca2+ concentration CaM is found to be 
in the apo form, however, the presence of the eNOS peptide enhances CaM’s C-lobe affinity for Ca2+ 
allowing it to interact and bind to the peptide.21,27,43 The macroscopic Ca2+ binding constants for CaM in 
the absence and presence of the eNOS peptide have previously been determined and showed the addition 
of eNOS peptide drastically increased CaM’s affinity of Ca2+ (logK1K2 and logK3K4 of 11.9 and 10.5 for 
CaM alone and 14.4 and 14.1 for CaM with eNOS).21 The slower association rate can be attributed to the 
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C-lobe of CaM undergoing a conformation change to the Ca2+-replete form while also binding to the 
peptide, and the N-lobe of CaM weakly interacting with the peptide in the Ca2+-deplete form. In contrast, 
at the saturated Ca2+ concentration CaM is already in the Ca2+-replete conformation with both lobes 
binding simultaneously to the peptide. The increased dissociation rate at the low Ca2+ concentration results 
from the fast dissociation of the loosely bound N-lobe followed by dissociation of the tightly bound C-
lobe, while at saturated Ca2+ the two tightly bound lobes of CaM are required to dissociate. A 1:1 (two 
state) conformation change model (A + B « AB « AB*) in which, the C-lobe of CaM binds the peptide 
to form the initial complex, AB, then the conformation of the complex is altered upon the loose association 
of the N-lobe, AB*, may be more suitable to describe this interaction. This type of fitting model has been 
previously used to fit sensorgram data for various CaM-target peptide interactions. 43,54–56 When the 
sensorgrams were fit using this model (Figure S1 and Table S1) the apparent KD values determined were 
quite similar to the KD values obtained using the simple fit model.  
The association and dissociation of CaM12 with eNOS at 225 nM Ca2+ can also be described by this low 
Ca2+ binding rationale, while at saturated Ca2+ the higher association rate is due to the lack of 
conformational change required by CaM12’s C-lobe (already Ca2+-replete at this Ca2+ concentration) 
before association with the peptide. CaM34’s weak binding to the eNOS peptide at 225 nM free Ca2+ shows 
that at this Ca2+ concentration the N-lobe is unable to bind Ca2+ in the presence of the peptide and thus 
CaM is unable to associate with the eNOS peptide (C-lobe of CaM is incapable of binding Ca2+). CaM12’s 
lower KD compared to CaM34’s shows when CaM only has a Ca2+ saturated N-lobe it has weaker binding 
with the peptide, whereas the C-lobe of CaM has increased binding affinity for the eNOS peptide.  
This SPR data helps us understand the different binding kinetics of CaM interacting with NOS during 
various intracellular Ca2+ signaling events, which may allow us to further understand the activation of 
NOS. Binding of CaM to eNOS at an initial increased intracellular Ca2+ concentration of 225 nM has a 
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decreased association rate compared to CaM binding eNOS at a saturating Ca2+ concentration, due to only 
the tight association of the C-lobe of CaM (instead of both lobes) to eNOS. The increase in the Ca2+ 
concentration allows the N-lobe of CaM to become Ca2+-replete and then bind to eNOS, resulting in a 
roughly threefold increase in binding affinity due to a decrease of the dissociation rate of the complex. 
Taking this all together the C-lobe of CaM is primarily responsible for the strong binding to the eNOS 
peptide, with the N-lobe enhancing this affinity, as has been proposed in other CaM studies.57 
This is the first study to determine an NMR structure of the CaM-eNOS complex at a free Ca2+ 
concentration that is a physiologically relevant elevated intracellular Ca2+ concentration. The structure 
and SPR data suggest that when the intracellular Ca2+ concentration is elevated to 225 nM the C-lobe of 
CaM first binds Ca2+ and to the N-terminus of eNOS’ CaM-binding domain, possibly along with part of 
the heme domain (which doesn’t shift during electron transfer), while the N-lobe of CaM is loosely 
associated to the C-terminus of eNOS’ CaM-binding domain and the FMN subdomain. In this dynamic 
state the less structured C-terminal region of the eNOS CaM binding domain would allow the FMN 
subdomain to have the flexibility to exist in a complex distribution of conformational states, correlating 
well with the dynamic N-lobe of CaM observed at 225 nM Ca2+. An increase in the intracellular Ca2+ 
concentration would result in the N-lobe of CaM binding Ca2+ and becoming tightly bound to the C-
terminus of eNOS’ CaM-binding domain. This would induce α-helical structure and alter the 
conformational state of the FMN subdomain, allowing for the possibility of a bridge to form between CaM 
and the FMN subdomain as observed in the crystal structure of CaM with the FMN subdomain and CaM 
binding domain of iNOS.39 This increased α-helical structure may be part of the triggering mechanism 
that restricts the movement of the FMN subdomain to conformations that allow for efficient electron 
transfer from the FMN to the heme. Our study provides a new structural insight into how CaM restricts 
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and regulates the dynamic conformational changes of the highly flexible FMN subdomain to allow for 
efficient electron transfer between the reductase and oxygenase domains.  
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Table 1. Statistics for the structural ensemble of the CaM−eNOS complex at 225 nM Ca2+  
 CaM-eNOS Complex 
NMR-derived distance and dihedral angle restraints 
 
NOE constraints 
Calmodulin eNOS peptide CaM-eNOS complex 
total 2836 86 37 
dihedral angles from 
TALOS+ 
280 14 N/A 
Total number of restraints 3253 
Structure statistics for the 20 lowest energy structures 
Mean deviation from ideal 
covalent geometry 
 
Bond lengths (Ǻ)  0.010 
Bond angles (deg.) 1.2 
Average pairwise RMSD 
(Ǻ) for all heavy atoms of 
the 20 lowest energy 
structures 
All Residues Ordered 
Residuesa 
C-lobeb N-lobec 
Backbone Atoms  2.3 1.9 0.6 0.9 
Heavy Atoms 2.6 2.2 1.1 1.4 
Ramachandran statistics (%)  
Residues in most favored 
region  
86.3 
Residues in additional 
allowed regions  
13.2 
Residues in generously 
allowed region  
0.4 
Residues in disallowed 
region 
0.0 
a Ordered residue ranges: 4A-78A, 81A-134A, 137A-147A, 154B-161B 
b C-lobe residues: 81A-148A 




Table 2. kon and koff rate constants of eNOS target peptide to CaM at 225 nM Ca2+ and sat Ca2+. 
 
kon (104 M-1s-1)a koff (10-4 s-1)a KD (10-9 M)a 
CaM-eNOS at sat Ca2+ 13.1 ± 4.8 3.5 ± 1.0 2.7 ± 0.2 
CaM-eNOS at 225 nM Ca2+ 7.8 ± 0.5 8.3 ± 0.7 10.7 ± 0.3 
CaM12-eNOS at sat Ca2+ 11.2 ± 0.8 15.9 ± 4.4 14.4 ± 4.0 
CaM12-eNOS at 225 nM Ca2+ 5.1 ± 0.4 9.1 ± 0.7 18.0 ± 2.7 
CaM34-eNOS at sat Ca2+b 5.8 ± 0.9 13.4 ± 0.3 22.7 ± 1.5 
a Data was fit in TraceDrawer using a 1:1 binding interaction model (A+B « AB) with standard 
deviation of three experiments. 






FIGURE CAPTIONS  
FIGURE 1. Solution structures of CaM bound to the eNOS CaM binding peptide at 225 nM Ca2+. 
Superposition of the ensemble of the 20 lowest-energy calculated NMR solution structures of (a) CaM 
bound to eNOS peptide at 225 nM Ca2+ and (d) the previously determined solution structures of CaM 
bound to eNOS peptide at saturated Ca2+. The superposition is aligned by the backbone atoms of the C-
lobe of CaM. Backbone atom traces of CaM are colored dark blue, and the eNOS peptide colored light 
blue. Cartoon ribbon view of the average solution structure of the CaM− eNOS complex at (b) 225 nM 
Ca2+ and (e) saturated Ca2+. Residues 1−40 of CaM (EF hand I) are colored red, residues 41−79 (EF hand 
II) purple, residues 80−114 (EF hand III) green, and residues 115−148 (EF hand IV) blue. The peptide is 
colored lighter blue. Calcium ions are colored green. CaM N and C termini are identified by N and C, 
while the peptide N and C termini are identified by N’ and C’.  Worm models of CaM-eNOS peptide 
complex at (c) 225 nM Ca2+ and (f) saturated Ca2+ illustrating their internal dynamics and amide H/D 
exchange data. The worm models were prepared using UCSF Chimera with the render by attribute 
function. The worm radius ranges from 0.25 (S2 value of 1), to 4 (S2 value of 0.4). Residues that display 
fast D2O exchange rates are colored red on the ribbon structure. Residues that display intermediate D2O 
exchange rates are colored light blue and residues that display slow D2O exchange rates are colored blue. 
The bound peptide is colored black and shown in wire form. 
FIGURE 2. Comparison of the solution structure of the CaM-eNOS peptide complex at 225 nM Ca2+ with 
the solution structures of saturated Ca2+ CaM-eNOS peptide complex and apoCaM. The solution 
structures of the CaM−eNOS peptide at 225 nM Ca2+ (dark colors) and at saturated Ca2+ (light colors) are 
aligned by superimposition of the backbone atoms of the C-lobes of CaM (a) viewed along the bound 
peptide from its N-terminus (N′) to its C-terminus (C′) and (b) rotated around the horizontal axis with the 
C-terminus of the bound peptide on the top. The solution structures of the CaM−eNOS peptide at 225 nM 
Ca2+ (dark colors) and apoCaM (light colors) are aligned by superimposition of the backbone atoms of 
the N-lobes of CaM (c) viewed along the bound peptide from its N-terminus (N′) to its C-terminus (C′) 
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and (d) rotated around the horizontal axis with the C-terminus of the bound peptide on the top. The color 
scheme for the EF hands is the same as that in Figure 1. 
FIGURE 3. Solution structures of CaM bound to the eNOS CaM binding peptide at 225 nM Ca2+ showing 
sidechain residues of CaM interacting with side chains of the anchor residues of the eNOS peptide. (A) 
Cartoon ribbon view of the average solution structure of the CaM− eNOS complex at 225 nM Ca2+ 
showing sidechain residues of CaM interacting with side chains of the anchor residues of the eNOS 
peptide. The side chains are colored by the same color scheme as that in Figure 1. (B) Zoom in of the C-
lobe of CaM showing sidechain residues of CaM interacting with side chains of the anchor residues of 
the N-terminus of the eNOS peptide (showing α-helical structure). (C) Zoom in of the N-lobe of CaM 
showing sidechain residues of CaM interacting with side chains of the anchor residues of the C-terminus 
of the eNOS peptide (showing random coil structure). 
FIGURE 4. SPR sensorgrams of the binding of various CaM constructs onto immobilized eNOS peptide 
at saturating Ca2+ (0.1 mM CaCl2) and 225 nM free Ca2+ on OpenSPR. Sensorgrams were recorded using 
increasing amounts of CaM (from 10 – 500 nM) in either the saturating Ca2+ (0.1 mM CaCl2) or 225 nM 
free Ca2+ buffer running buffer during the association phase. Dissociation of the CaM-eNOS complex was 
observed by running either saturating Ca2+ (0.1 mM CaCl2) or 225 nM free Ca2+ buffer without CaM over 
the flow cell.  
FIGURE 5. KD versus koff for various CaM constructs and eNOS peptides at saturating Ca2+ (0.1 mM 
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